Orphazyme A/S PEG Ratio

Orphazyme A/S (ORPH) currently reports a PEG ratio of -19.75. That is below the Healthcare sector average of 1.26. Use the charts on this page to explore Orphazyme A/S's PEG ratio history and peer comparisons.

Orphazyme A/S's PEG ratio of -19.75 is lower than the Healthcare sector average of 1.26. That is roughly 1671.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The PEG ratio is a valuation multiple that relates Orphazyme A/S's market price to a fundamental measure such as earnings, sales, or book value. At -19.75, ORPH can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current PEG ratio of -19.75, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 1.26. From there, open related valuation or income-statement pages for Orphazyme A/S, and consider following ORPH for alerts when major investors trade the stock.

Orphazyme A/S is classified in the Healthcare sector. On PEG ratio, it currently shows -19.75 versus a sector average near 1.26. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ORPH with unrelated industries.